Hellerup, Denmark

Ole Baadsgaard

This inventor holds 31 USPTO granted patents and 17 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Genmab A+s, Cormorant Pharmaceuticals Ab, Medarex Inc.. Active years: 2006-2022.

USPTO Granted Patents = 31 

% Patents Active = 77.4

 

 

Average Co-Inventor Count = 6.2

ph-index = 9

Forward Citations = 349(Granted Patents)


Location History:

  • Kyrkogatan, SE (2006)
  • Malmo, SE (2007 - 2015)
  • Hellerup, DK (2009 - 2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Monoclonal Antibodies
Interleukin 8
HER2
EGFR
CD25
Tissue Factor
CD38
IL-15
Cancer Treatment
Antibody Therapy
Combination Treatment
Nucleic Acid Encoding
31 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ole Baadsgaard

Introduction: Ole Baadsgaard, a visionary inventor hailing from Hellerup, Denmark, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Baadsgaard's recent patents include cutting-edge advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Baadsgaard has established himself as a pioneer in the tech industry, holding numerous patents that have revolutionized various sectors.

Collaborations: Throughout his career, Baadsgaard has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His collaborative spirit has led to the development of cutting-edge products that have shaped the industry.

Conclusion: Ole Baadsgaard's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire the next generation of inventors and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…